DE69333076D1 - Test und behandlung von demyelinierenden krankheiten wie multiple sklerosis - Google Patents

Test und behandlung von demyelinierenden krankheiten wie multiple sklerosis

Info

Publication number
DE69333076D1
DE69333076D1 DE69333076T DE69333076T DE69333076D1 DE 69333076 D1 DE69333076 D1 DE 69333076D1 DE 69333076 T DE69333076 T DE 69333076T DE 69333076 T DE69333076 T DE 69333076T DE 69333076 D1 DE69333076 D1 DE 69333076D1
Authority
DE
Germany
Prior art keywords
multiple sclerosis
testing
demyelinating diseases
relates
present
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69333076T
Other languages
English (en)
Other versions
DE69333076T2 (de
Inventor
Ellis L Kline
Daniel H Zimmerman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Signal Coordinating Therapy Inc Pendleton S Us
Cell Med Inc
Original Assignee
Molecular Rx Inc
Cell Med Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Molecular Rx Inc, Cell Med Inc filed Critical Molecular Rx Inc
Application granted granted Critical
Publication of DE69333076D1 publication Critical patent/DE69333076D1/de
Publication of DE69333076T2 publication Critical patent/DE69333076T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4713—Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/829—Blood
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/837—Lymph; lymph-glands; thymus
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/838—Marrow; spleen
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/839—Nerves; brain
DE69333076T 1992-12-18 1993-12-17 Test und behandlung von demyelinierenden krankheiten wie multiple sklerosis Expired - Fee Related DE69333076T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US166171 1980-07-07
US99264192A 1992-12-18 1992-12-18
US992641 1992-12-18
US16617193A 1993-12-16 1993-12-16
PCT/US1993/012296 WO1994014846A1 (en) 1992-12-18 1993-12-17 Assay and treatment for demyelinating diseases such as multiple sclerosis

Publications (2)

Publication Number Publication Date
DE69333076D1 true DE69333076D1 (de) 2003-08-07
DE69333076T2 DE69333076T2 (de) 2004-04-15

Family

ID=26862018

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69333076T Expired - Fee Related DE69333076T2 (de) 1992-12-18 1993-12-17 Test und behandlung von demyelinierenden krankheiten wie multiple sklerosis

Country Status (9)

Country Link
US (2) US5645997A (de)
EP (1) EP0674661B1 (de)
AT (1) ATE244299T1 (de)
AU (1) AU689091B2 (de)
DE (1) DE69333076T2 (de)
NZ (1) NZ259636A (de)
PL (1) PL177771B1 (de)
RU (1) RU2137131C1 (de)
WO (1) WO1994014846A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6861053B1 (en) * 1999-08-11 2005-03-01 Cedars-Sinai Medical Center Methods of diagnosing or treating irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth
US7048906B2 (en) 1995-05-17 2006-05-23 Cedars-Sinai Medical Center Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions
US6562629B1 (en) 1999-08-11 2003-05-13 Cedars-Sinai Medical Center Method of diagnosing irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth by detecting the presence of anti-saccharomyces cerivisiae antibodies (asca) in human serum
US20070038231A1 (en) 1999-05-28 2007-02-15 Ferree Bret A Methods and apparatus for treating disc herniation and preventing the extrusion of interbody bone graft
US6977169B2 (en) * 2000-04-07 2005-12-20 Kline Ellis L Methods and compositions for treating neoplasms
CA2774959C (en) 2000-08-04 2016-05-31 Dmi Biosciences, Inc. Method of using diketopiperazines and composition containing them
JP2005500038A (ja) * 2001-06-22 2005-01-06 ヤンゼン、ブルクハルト 多発性硬化症のヒトの診断方法
DK1571970T3 (da) * 2002-10-02 2011-11-28 Dmi Biosciences Inc Diagnose og monitorering af sygdomme
PT2537524T (pt) * 2003-05-15 2016-09-05 Ampio Pharmaceuticals Inc Tratamento de doenças mediadas pela célula t
US20060160151A1 (en) * 2005-01-10 2006-07-20 Baylor College Of Medicine Method of quantitative immunohistochemistry and in situ hybridization
WO2006076641A2 (en) * 2005-01-14 2006-07-20 Monosol Rx, Llc Methods and compositions for preventing and treating a disease related to glycan dysregulation
WO2009146320A1 (en) 2008-05-27 2009-12-03 Dmi Life Sciences, Inc. Therapeutic methods and compounds
EP2613786A4 (de) 2010-09-07 2013-10-23 Dmi Acquisition Corp Behandlung von erkrankungen
MY167804A (en) 2011-10-10 2018-09-26 Ampio Pharmaceuticals Inc Treatment of degenerative joint disease
EP2765968A4 (de) 2011-10-10 2015-01-21 Ampio Pharmaceuticals Inc Implantierbare medizinprodukte mit erhöhter immuntoleranz sowie verfahren zur herstellung und implantation
JP6231484B2 (ja) 2011-10-28 2017-11-15 アンピオ ファーマシューティカルズ，インコーポレイテッド 鼻炎の処置
CA2906864A1 (en) 2013-03-15 2014-09-18 Ampio Pharmaceuticals, Inc. Compositions for the mobilization, homing, expansion and differentiation of stem cells and methods of using the same
JP6723222B2 (ja) 2014-08-18 2020-07-15 アンピオ ファーマシューティカルズ，インコーポレイテッド 関節病態の治療
EP3310375A4 (de) 2015-06-22 2019-02-20 Ampio Pharmaceuticals, Inc. Verwendung von niedermolekularen fraktionen von humanem serumalbumin bei der behandlung von erkrankungen

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3932601A (en) * 1971-04-07 1976-01-13 Cornell Research Foundation, Inc. Method and composition for the diagnosis of equine infectious anemia virus infection by using agar-gel-immunodiffusion reaction
US3929982A (en) * 1971-11-05 1975-12-30 Cornell Res Foundation Inc Method and composition for the diagnosis of equine infectous anemia virus infection by using agar-gel-immunodiffusion reaction
US3864481A (en) * 1972-12-14 1975-02-04 St Lukes Hospital Anti disease producing synthetic material for the prevention suppression and diagnosis of multiple sclerosis and method of treatment therefor
US4113858A (en) * 1975-01-20 1978-09-12 St. Luke's Hospital Novel compounds, compositions and methods of their use
US4294818A (en) * 1979-07-30 1981-10-13 University Patents, Inc. Methods and materials for detection of multiple sclerosis
US4376110A (en) * 1980-08-04 1983-03-08 Hybritech, Incorporated Immunometric assays using monoclonal antibodies
US4486530A (en) * 1980-08-04 1984-12-04 Hybritech Incorporated Immunometric assays using monoclonal antibodies
US4918163A (en) * 1985-09-27 1990-04-17 Pfizer Inc. Monoclonal antibodies specific for lipid-A determinants of gram negative bacteria
AU1765692A (en) * 1991-03-08 1992-10-06 Uab Research Foundation, The Novel protein, method and products for detection of oligodendrocytes
ES2144418T3 (es) * 1991-05-31 2000-06-16 Connetics Corp Peptidos de receptores de celulas t como agentes terapeuticos para enfermedades relacionadas con el sistema inmunitario.

Also Published As

Publication number Publication date
PL309637A1 (en) 1995-10-30
NZ259636A (en) 1997-10-24
RU2137131C1 (ru) 1999-09-10
WO1994014846A1 (en) 1994-07-07
AU689091B2 (en) 1998-03-26
US5645997A (en) 1997-07-08
US5883227A (en) 1999-03-16
ATE244299T1 (de) 2003-07-15
AU5850994A (en) 1994-07-19
PL177771B1 (pl) 2000-01-31
DE69333076T2 (de) 2004-04-15
EP0674661A4 (de) 1997-12-10
EP0674661B1 (de) 2003-07-02
EP0674661A1 (de) 1995-10-04

Similar Documents

Publication Publication Date Title
DE69333076D1 (de) Test und behandlung von demyelinierenden krankheiten wie multiple sklerosis
Savage et al. Antineutrophil cytoplasm antibodies in Kawasaki disease.
EP0671920A4 (de) Ein anti-idiotypischer antikörper und seine verwendung in der diagnose und therapie von hiv-verwandten krankheiten.
ES2061730T3 (es) Nuevos anticuerpos.
DE68927459D1 (de) Nachweis einer neurologischen Krankheit oder einer Funktionsstörung
NO941370L (no) Rekombitope peptider
DE3780480T2 (de) Test fuer menschlichen brustkrebs.
Moutsopoulos et al. B lymphocyte antigens in sicca syndrome
DE3879085T2 (de) Snrnp-a-antigen und fragmente davon.
Schneiderman et al. Activation of the alternative pathway of complement by twelve different rabbit-mouse chimeric transfectoma IgA isotypes.
DK0764273T3 (da) Alfa B crystallin til anvendelse i diagnose og terapi af autoimmune sygdomme, især multipel sklerose
FI922666A0 (fi) Diagnostiskt foerfarande.
WUEPPER et al. Serologic tests for syphilis and the false-positive reactor
CA2151945A1 (en) Assay and treatment for demyelinating diseases such as multiple sclerosis
Mach et al. D-penicillamine: a modulator of anti-DNA antibodies production.
MX9704717A (es) Antigeno, anticuerpos y ensayo de diagnostico para la enfermedad de alzheimer.
Salo et al. Quantitative Reiter protein complement-fixation test.
KR970073606A (ko) 항 인체 인터루킨-6 항체 및 이를 이용한 인체 인터루킨-6의 검정
DE69123724T2 (de) Verfahren zur diagnose von hiv-infektionen
DK182188A (da) Humant tumorassocieret antigen
PT65676B (fr) Procede d'isolement et de caracterization de determinees proteines associees aux membranes des celules cancereuses et obtention des correspondants antisoros et anticorps qui permettent etablir un diagnostique et traitement du cancera la base de la detection de ces proteines
SU1739559A1 (ru) Штамм вируса aphtae epizooticae типа o, используемый для изготовления диагностических сывороток и антигенных препаратов

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: CELL MED, INC., BETHESDA, MD., US

Owner name: SIGNAL COORDINATING THERAPY INC., PENDLETON, S, US

8339 Ceased/non-payment of the annual fee